M. Toi

Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3

M.P. Goetz, M. Toi, Jens Huober et al. · Annals of Oncology · 2024 · 206 citations · Full text

Medicine, Oncology, Pharmacology +16

Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer

Hiroji Iwata, Nobuaki Sato, N Masuda et al. · Japanese Journal of Clinical Oncology · 2011 · 56 citations · Full text

Medicine, Oncology, Pharmacology +15

Clinical significance of plasma nucleosome levels in cancer patients

Katsumasa Kuroi, Chie Tanaka, M. Toi · International Journal of Oncology · 2001 · 50 citations

Medicine, Oncology, Pharmacology +14

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Giuseppe Viale, O. Pagani, Emiel J. Rutgers et al. · UNC Libraries · 2025 · 17 citations · Full text

Medicine, Oncology, Breast Oncology +12

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer

Norikazu Masuda, Hirofumi Mukai, Kenichi Inoue et al. · Breast Cancer · 2019 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17